Mometasone Furoate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

97 API Suppliers, 36 USDMF, 28 CEP/COS, 9 JDMF, 19 EU WC, 9 KDMF, 31 NDC API, 50 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

93 Drugs in Development

93 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

371 FDF Dossiers, 41 FDA Orange Book, 183 Europe, 21 Canada, 59 Australia, 29 South Africa, 38 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT;TOPICAL - 0.1%, CREAM;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, LOTION;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, AEROSOL, METERED;INHALATION - 0.05MG/INH, AEROSOL, METERED;INHALATION - 0.10MG/INH, AEROSOL, METERED;INHALATION - 0.20MG/INH, SPRAY, METERED;NASAL - 0.05MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, POWDER;INHALATION - 0.11MG/INH, POWDER;INHALATION - 0.22MG/INH, AEROSOL, METERED;INHALATION - 0.005MG/INH;0.05MG/INH, AEROSOL, METERED;INHALATION - 0.005MG/INH;0.1MG/INH, AEROSOL, METERED;INHALATION - 0.005MG/INH;0.2MG/INH

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Rochem International Inc, 1 SPI Pharma, 5 DKSH, 2 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 6 Kirsch Pharma, 6 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 4 BASF, 1 CD Formulation, 3 DFE Pharma, 2 Finar, 7 Gangwal Chemicals, 1 Ideal Cures, 5 Kerry, 2 Keval Exports, 1 Kima Chemical, 6 Microlex e.U, 1 Nanjing Bold Chemical, 1 Nitika Pharmaceutical Specialities, 1 Pharmatrans-Sanaq, 1 Pluviaendo, 1 Prachin Chemical, 9 Roquette, 6 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 8 Sigachi Industries, 1 Silverline Chemicals, 1 The Dow Chemical Company, 1 Valens Pharmachem, 1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

21 Solubilizers, 20 Thickeners and Stabilizers, 17 Parenteral, 16 Fillers, Diluents & Binders, 16 Direct Compression, 11 Topical, 9 Coating Systems & Additives, 9 Film Formers & Plasticizers, 9 Granulation, 8 Co-Processed Excipients, 6 Rheology Modifiers, 5 Disintegrants & Superdisintegrants, 5 Emulsifying Agents, 4 Taste Masking, 3 Chewable & Orodispersible Aids, 3 Surfactant & Foaming Agents, 3 Controlled & Modified Release, 2 Lubricants & Glidants, 2 Coloring Agents, 1 API Stability Enhancers

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 49 News #PharmaBuzz

GLOBAL SALES INFORMATION

14 US Medicaid Prescriptions, 57 Regulatory FDF Prices, 16 Annual Reports

MARKET PLACE

17 APIs, 4 FDF Dossiers

PATENTS & EXCLUSIVITIES

23 US Patents, 1 US Exclusivities, 34 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 1 USP, 2 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 19625 / DOSAGE - CREAM;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Mometasone Furoate(UNII: 04201GDN4R) (Mometasone - UNII:8HR4QJ6DW8)	Mometasone Furoate	1mg in 1

Inactive Ingredients

Ingredient Name	A-S Medication Solutions LLC	Merck Sharp & Dohme Corp.
aluminum starch octenylsuccinate(I9PJ0O6294)
hexylene glycol(KEH0A3F75J)
hydrogenated soybean lecithin(H1109Z9J4N)
petrolatum(4T6H12BN9U)
phosphoric acid(E4GA8884NN)
polyoxyl 20 cetostearyl ether(YRC528SWUY)
propylene glycol monopalmitostearate(F76354LMGR)
stearyl alcohol(2KR89I4H1Y)
titanium dioxide(15FIX9V2JP)
water(059QF0KO0R)
white wax(7G1J5DA97F)

Setid Fc88c0f0 C9b5 492d 89ff Ea6af4dfd19b Applno 19625 Form Cream Topical Dosage 0 1 - Drug Product Composition: Mometasone Furoate